These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19063828)

  • 1. Fixed drug eruption: a prototypic disorder mediated by effector memory T cells.
    Mizukawa Y; Shiohara T
    Curr Allergy Asthma Rep; 2009 Jan; 9(1):71-7. PubMed ID: 19063828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-gamma-producing effector CD8+ T cells and IL-10-producing regulatory CD4+ T cells in fixed drug eruption.
    Teraki Y; Shiohara T
    J Allergy Clin Immunol; 2003 Sep; 112(3):609-15. PubMed ID: 13679823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption.
    Mizukawa Y; Yamazaki Y; Shiohara T
    Br J Dermatol; 2008 Jun; 158(6):1230-8. PubMed ID: 18363767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed drug eruption: pathogenesis and diagnostic tests.
    Shiohara T
    Curr Opin Allergy Clin Immunol; 2009 Aug; 9(4):316-21. PubMed ID: 19474709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fixed drug eruption: the dark side of activation of intraepidermal CD8+ T cells uniquely specialized to mediate protective immunity.
    Shiohara T; Mizukawa Y
    Chem Immunol Allergy; 2012; 97():106-21. PubMed ID: 22613857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fixed drug eruption: a disease mediated by self-inflicted responses of intraepidermal T cells.
    Shiohara T; Mizukawa Y
    Eur J Dermatol; 2007; 17(3):201-8. PubMed ID: 17478380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct evidence for interferon-gamma production by effector-memory-type intraepidermal T cells residing at an effector site of immunopathology in fixed drug eruption.
    Mizukawa Y; Yamazaki Y; Teraki Y; Hayakawa J; Hayakawa K; Nuriya H; Kohara M; Shiohara T
    Am J Pathol; 2002 Oct; 161(4):1337-47. PubMed ID: 12368207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization.
    Teraki Y; Shiohara T
    Dermatology; 2004; 209(1):29-32. PubMed ID: 15237264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic T lymphocytes and phenotypically abnormal epidermal dendritic cells in fixed cutaneous eruptions.
    Murphy GF; Guillén FJ; Flynn TC
    Hum Pathol; 1985 Dec; 16(12):1264-71. PubMed ID: 2415442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunological basis of lichenoid tissue reaction.
    Shiohara T; Mizukawa Y
    Autoimmun Rev; 2005 Apr; 4(4):236-41. PubMed ID: 15893718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of fixed drug eruption: the role of skin-resident T cells.
    Shiohara T; Mizukawa Y; Teraki Y
    Curr Opin Allergy Clin Immunol; 2002 Aug; 2(4):317-23. PubMed ID: 12130946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What is new in fixed drug eruption?
    Shiohara T
    Dermatology; 1995; 191(3):185-7. PubMed ID: 8534934
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathophysiology of Skin Resident Memory T Cells.
    Tokura Y; Phadungsaksawasdi P; Kurihara K; Fujiyama T; Honda T
    Front Immunol; 2020; 11():618897. PubMed ID: 33633737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial Role of Viral Reactivation in the Development of Severe Drug Eruptions: a Comprehensive Review.
    Shiohara T; Ushigome Y; Kano Y; Takahashi R
    Clin Rev Allergy Immunol; 2015 Oct; 49(2):192-202. PubMed ID: 24736996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor (TCR) repertoire and function of human epidermal T cells: restricted TCR V alpha-V beta genes are utilized by T cells residing in the lesional epidermis in fixed drug eruption.
    Komatsu T; Moriya N; Shiohara T
    Clin Exp Immunol; 1996 May; 104(2):343-50. PubMed ID: 8625531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption.
    Choi HJ; Ku JK; Kim MY; Kang H; Cho SH; Kim HO; Park YM
    Br J Dermatol; 2006 Mar; 154(3):419-25. PubMed ID: 16445769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plaque psoriasis vs. atopic dermatitis and lichen planus: a comparison for lesional T-cell subsets, epidermal proliferation and differentiation.
    Bovenschen HJ; Seyger MM; Van de Kerkhof PC
    Br J Dermatol; 2005 Jul; 153(1):72-8. PubMed ID: 16029329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed drug eruptions: evidence for a cytokine-mediated process.
    Smoller BR; Luster AD; Krane JF; Krueger J; Gray MH; McNutt NS; Hsu A; Gottlieb AB
    J Cutan Pathol; 1991 Feb; 18(1):13-9. PubMed ID: 1827131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of IL-10-producing CD4+ and CD8+ T cells in fixed drug eruption.
    Teraki Y; Kokaji T; Shiohara T
    Dermatology; 2006; 213(2):83-7. PubMed ID: 16902283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing Human Skin Contains Lymphocytes Demonstrating a Memory Signature.
    Dhariwala MO; Karthikeyan D; Vasquez KS; Farhat S; Weckel A; Taravati K; Leitner EG; Clancy S; Pauli M; Piper ML; Cohen JN; Ashouri JF; Lowe MM; Rosenblum MD; Scharschmidt TC
    Cell Rep Med; 2020 Nov; 1(8):100132. PubMed ID: 33294857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.